Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Therabron Therapeutics Inc.
DescriptionSecretoglobin protein based on SCGB3A2 protein
Molecular Target Secretoglobin family 3A member 2 (SCGB3A2)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentDiscovery
Standard IndicationPulmonary fibrosis
Indication DetailsTreat idiopathic pulmonary fibrosis (IPF)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today